A UK pharmaceutical company takes drug price hiking to new heights of cruelty

The Competition and Markets Authority (CMA) has accused UK pharmaceutical company Actavis of jacking up the price of a life-saving drug by 12,000%.

Spotlight

Spotlight

Related News